|
Forward-looking intelligence allows you time to act. View this video on our restructuring content to see how you can benefit from our expertise.
| ||
NOT A SUBSCRIBER?Enzon to sell unit to Sigma-TauPosted on November 9, 2009 4:00 PM
Enzon Pharmaceuticals Inc. agreed Monday to sell its drug business to a unit of Italian drug company Sigma-Tau SpA for about $327 million to focus on its pipeline and technology platforms.
The Bridgewater, N.J., pharma company issued a statement saying it would receive $300 million in cash when the deal closes, which is expected in the first quarter of 2010. It will also receive as much as $27 million if the operations meet certain milestones and 5% to 10% royalties through 2014. This is a free content preview. Subscribers enjoy access to all stories in full as well as second-to-none market intelligence. Dig deeper, with Pipeline.
Most searched keywords
|
|
EXISTING USERS Missing a product? |
Michael Crosby mcrosby@thedeal.com 212.313.9325 |
Martha Brown mbrown@thedeal.com 212.313.9218 |